Skip to main content

CONTROL DE LAS TRICOSTRONGILIDOSIS OVINAS: DISEÑO, SINTESIS Y ENSAYOS CLINICOS DE EFICACIA DE NUEVAS MOLECULAS DE ACCION ANTIHELMINTICA

AGL2016-79813-C2-1-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE LEÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 20
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery

  • Álvarez Velilla, Raquel
  • Gutiérrez Corbo, María del Camino
  • Punzón, Carmen
  • Pérez Pertejo, Maria Yolanda
  • Balaña Fouce, Rafael
  • Fresno, Manuel
  • Reguera Torres, Rosa María
[EN] Background Visceral leishmaniasis is a neglected parasitic disease with no vaccine available and its pharmacological treatment is reduced to a limited number of unsafe drugs. The scarce readiness of new antileishmanial drugs is even more alarming when relapses appear or the occurrence of hard-to-treat resistant strains is detected. In addition, there is a gap between the initial and late stages of drug development, which greatly delays the selection of leads for subsequent studies. Methodology/Principal findings In order to address these issues, we have generated a red-shifted luminescent Leishmania infantum strain that enables long-term monitoring of parasite burden in individual animals with an in vivo limit of detection of 10 6 intracellular amastigotes 48 h postinfection. For this purpose, we have injected intravenously different infective doses (10 4 —5x10 8 ) of metacyclic parasites in susceptible mouse models and the disease was monitored from initial times to 21 weeks postinfection. The emission of light from the target organs demonstrated the sequential parasite colonization of liver, spleen and bone marrow. When miltefosine was used as proof-of-concept, spleen weight parasite burden and bioluminescence values decreased significantly. Conclusions In vivo bioimaging using a red-shifted modified Leishmania infantum strain allows the appraisal of acute and chronic stage of infection, being a powerful tool for accelerating drug development against visceral leishmaniasis during both stages and helping to bridge the gap between early discovery process and subsequent drug development., SI, Funding: RAV received a postdoctoral fellowship from Tres Cantos Open Lab Foundation CBM-ULe_TC178 TCOLF (http://www.openlabfoundation.org). MCGC received a predoctoral fellowship from Consejería de Educación de la Junta de Castilla y León (http://www.educa.jcyl.es/es). RBF was granted by Ministerio de Economía y Competitividad del Gobierno de España, AGL2016-79813-C2-1R (http://www.mineco.gob.es/portal/site/mineco/) and Consejería de Educación de la Junta de Castilla y León LE020P17 (http://www.educa.jcyl.es/es). MFE was granted by Tres Cantos Open Lab Foundation CBM-ULe_TC178 TCOLF (http://www.openlabfoundation.org). RRT was funded by Ministerio de Economía y Competitividad del Gobierno de España, SAF2017-83575-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics

  • Sepúlveda Crespo, Daniel
  • Reguera Torres, Rosa María
  • Rojo Vázquez, Francisco Antonio
  • Balaña Fouce, Rafael
  • Martínez Valladares, María
[EN] Helminthiasis is one of the gravest problems worldwide. There is a growing concern on less available anthelmintics and the emergence of resistance creating a major threat to human and livestock health resources. Novel and broad-spectrum anthelmintics are urgently needed. The free-living nematode Caenorhabditis elegans could address this issue through automated high-throughput technologies for the screening of large chemical libraries. This review discusses the strong advantages and limitations for using C elegans as a screening method for anthelmintic drug discovery. C elegans is the best model available for the validation of novel effective drugs in treating most, if not all, helminth infections, and for the elucidation the mode of action of anthelmintic candidates. This review also focuses on available technologies in the discovery of anthelmintics published over the last 15 years with particular attention to high-throughput technologies over conventional screens. On the other hand, this review highlights how combinatorial and nanomedicine strategies could prolong the use of anthelmintics and control resistance problems., SI, Financial support from the Ministerio de Economía y Competitividad (MINECO, AEI, FEDER, UE) [MINECO: AGL2016-79813-C2-1R], Junta de Castilla y León co-financed by FEDER, UE [LE020P17] and EDCTP-funded project led by ISGlobal [RIA2017NCT-1845] is gratefully acknowledged. DSC is supported by postdoctoral scholarships from the Junta de Castilla y León co-financed by FEDER to UIC108 [LE020P17]. MMV is supported by the Spanish “Ramón y Cajal” Programme, Ministry of Economy and Competitiveness (Ministerio de Economía y Competitividad) (RYC-2015-18368).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Anthelmintic activity of amino alcohols against eggs and larvae of the ovine nematode Teladorsagia circumcincta

  • Valderas García, Elora
  • Álvarez Bardó, M.
  • Balaña-Fouce, Rafael
  • del Olmo, Esther
  • Martínez Valladares, María
Póster presentado al: 2nd Working Groups Meeting COMBAR (Combatting Anthelmintic Resistance in Ruminants). León, 26-27 Septiembre 2018., Study funded by AGL2016-79813-C2-1/2-R, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

In vitro effect of benzalphthalides and phtalazinones against different eggs and larvae of Teladorsagia circumcincta

  • Valderas García, Elora
  • Álvarez Bardó, M.
  • Balaña-Fouce, Rafael
  • del Olmo, Esther
  • Martínez Valladares, María
Póster presentado al: 2nd Working Groups Meeting COMBAR (Combatting Anthelmintic Resistance in Ruminants). León, 26-27 Septiembre 2018., Study funded by AGL2016-79813-C2-1/2-R, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

New synthetic benzimidazole with potential anthelmintic activity

  • Valderas García, Elora
  • Álvarez Bardó, M.
  • Balaña-Fouce, Rafael
  • del Olmo, Esther
  • Martínez Valladares, María
Póster presentado al: 2nd Working Groups Meeting COMBAR (Combatting Anthelmintic Resistance in Ruminants). León, 26-27 Septiembre 2018., Study funded by AGL2016-79813-C2-1/2-R, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Anthelmintic activity of synthetic molecules on eggs and larvae of the gastrointestinal nematode Teladorsagia circumncincta

  • Valderas García, Elora
  • Balaña-Fouce, Rafael
  • del Olmo, Esther
  • Martínez Valladares, María
Trabajo presentado al: 2nd International Conference on Global Challenges in Neglected Tropical Diseases. San Juan, Puerto Rico, 25-27 Junio, 2018., Study funded by AGL2016-79813-C2-1-R; AGL2016-79813-C2-1-R and Junta de Castilla y León LE020P17 co-financed with Fondos FEDER (UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Potential anthelmintic activity of a certain series of new molecules (benzalphthalides and phtalazinones) against different phases of the gastrointestinal nematode Teladorsagia circumncincta

  • Valderas García, Elora
  • Balaña-Fouce, Rafael
  • del Olmo, Esther
  • Martínez Valladares, María
Trabajo presentado al: 2nd International Conference on Global Challenges in Neglected Tropical Diseases. San Juan, Puerto Rico, 25-27 Junio, 2018., Study funded by AGL2016-79813-C2-1-R; AGL2016-79813-C2-1-R and Junta de Castilla y León LE020P17 co-financed with Fondos FEDER (UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: Potential antitumour dual agents

  • González-Hernández, Elena
  • Aparicio, Rubén
  • Garayoa, Mercedes
  • Montero, María J.
  • Sevilla, Mª Ángeles
  • Pérez-Melero, Concepción
The use of multitarget drugs has evolved as an alternative to “magic bullets” for the treatment of complex diseases such as cancer, in order to affect simultaneously several targets relevant to the disease. We have designed and synthesized a series of dual agents as both Eg5 inhibitors and calcium channel blockers, bearing a 4-aryldihydropyrimidine core. Compound 2 (aryl: 3-nitrophenyl) was selected as potential dual agent due to displaying both activities: it is a vasorelaxant agent (>90% relaxation at 10−5 M in KCl-precontracted aorta rings), it decreases the response to calcium and it is cytotoxic to MCF-7 (breast), HCT-116 (colon) and A-549 (lung) cancer cell lines. The dual mechanism of action was confirmed by blocking (−)-BAY K8644-induced vascular contraction and production of monopolar spindles, typical of Eg5 inhibition. Docking suggests that both (R) and (S)-enantiomers could bind Eg5., Financial support from Spanish Ministry of Economy and Competitiveness (MINECO) and European FEDER funds (grant AGL2016-79813-C2-1-R).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Current and promising novel drug candidates against visceral leishmaniasis

  • Reguera, R.M.
  • Pérez-Pertejo, Yolanda
  • Gutiérrez-Corbo, C.
  • Domínguez-Asenjo, Bárbara
  • Ordonez, C.
  • García Estrada, Carlos
  • Martínez Valladares, María
  • Balaña-Fouce, Rafael
20 páginas, 2 tablas, 4 figuras., Leishmaniasis is a group of zoonotic diseases caused by a trypanosomatid parasite mostly in impoverished populations of low-income countries. In their different forms, leishmaniasis is prevalent in more than 98 countries all over the world and approximately 360-million people are at risk. Since no vaccine is currently available to prevent any form of the disease, the control strategy of leishmaniasis mainly relies on early case detection followed by adequate pharmacological treatment that may improve the prognosis and can reduce transmission. A handful of compounds and formulations are available for the treatment of leishmaniasis in humans, but only few of them are currently in use since most of these agents are associated with toxicity problems such as nephrotoxicity and cardiotoxicity in addition to resistance problems. In recent decades, very few novel drugs, new formulations of standard drugs or combinations of them have been approved against leishmaniasis. This review highlights the current drugs and combinations that are used medical practice and recent advances in new treatments against leishmaniasis that were pointed out in the recent 2nd Conference, Global Challenges in Neglected Tropical Diseases, held in San Juan, Puerto Rico in June 2018, emphasizing the plethora of new families of molecules that are bridging the gap between preclinical and first-in-man trials in next future., Financial support from the Ministerio de Economía y Competitividad (MINECO, AEI, FEDER, UE) [MINECO, Funder Id: http://dx.doi.org/10.13039/501100003329, AGL2016-79813-C2-1R and Funder Id: http://dx.doi.org/10.13039/501100003329, SAF2017-83575-R], and the Junta de Castilla y León co-financed by FEDER, UE [LE020P17] is gratefully acknowledged. CGC and BGA are supported by scholarships from the Junta de Castilla y León co-financed by FEDER., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

A combined, automated high-throughput system for the quantification of the viability of the free-living nematode Caenorhabditis elegans

  • Sepúlveda-Crespo, D.
  • Valderas García, Elora
  • Balaña-Fouce, Rafael
  • Martínez Valladares, María
JOINT COMBAR - ACSRPC meeting: Anthelmintic Resistance in Ruminants: Who cares? Abstract Book, Poster Presentations, pp. 88. Gante (Bélgica). 27-29 agosto 2019., MINECO (AGL2016-79813-C2-1R, SAF2017-83575), FEDER, LE020P17, FPU16/03536 and RYC-2015-18368
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

New benzimidazole derivates as potential anthelmintic compounds

  • Valderas García, Elora
  • Álvarez, M.
  • Castilla Gómez de Agüero, Verónica
  • Balaña-Fouce, Rafael
  • del Olmo, Esther
  • Martínez Valladares, María
Trabajo presentado al: 27th International Conference of the World Association for the Advancement of Veterinary Parasitology. Abstract book, Oral Sesion OA36.08, pp. 135. Madison (USA). 7-11 julio 2019., Gastrointestinal nematode infections cause direct and indirect losses of great economic impact worldwide by decreasing productions yields and increasing health care cost in sheep. Thus, the aim of this study was to test the nematocidal e@ect of a new collection of benzimidazole derivatives against Teladorsagia circumcincta by in vitro methods. Compounds were tested in eggs, first stage larvae (L1) and thrid stage larvae (L3) by means of the Egg Hatch Assay, L1 Mortality Assay and the Larval Migration Inhibition Assay. An initial screening was done at a single concentration of 50 $M; those molecules that showed an activity higher than >90% were selected to to determine their half maximal e@ective concentration (EC50) and were tested again against a resistant strain. Finally, the anthelmintic e@ect was compared with their cytotoxicity in two digestive established cell lines, Caco-2 and HepG2, and their corresponding concentrations required to reduce cell viability by 50% (CC50) were determined in order to establish a selective index (SI) for each molecules. Only 5 of the 18 compounds were able to arrest the hatching of eggs in the susceptible strain in more than 99% at 50 $M and 4 of them were also able to produce a significant e@ect on the resistant strain used in the current study. Considering only those compounds that have a significant e@ect, their CC50 values were very homogeneous between Caco-2 and HepG2, which makes that SI values were comprised between 1.84 to 3.60 for Caco-2 cells and 1.53 and 2.73 for HepG2 cells. These results indicate that they could be good candidates for further studies to determine their in vivo activity., Study funded by AGL2016-79813-C2- 1-R, Junta de Castilla y León co-financed by FEDER [LE020P17], EVG by FPU17/00627 and MMV by RYC-2015-18368
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In vitro anthelmintic activity and safety of different plant species against the ovine gastrointestinal nematode Teladorsagia circumcincta

  • Esteban-Ballesteros, Myriam
  • Sanchis, J.
  • Gutiérrez-Corbo, C.
  • Balaña-Fouce, Rafael
  • Rojo Vázquez, Francisco Antonio
  • González Lanza, Camino
  • Martínez Valladares, María
6 páginas, 4 tablas., The present study was conducted to evaluate the in vitro anthelmintic activity and safety of methanolic and aqueous extracts of 9 plants against the ovine GIN Teladorsagia circumcincta. Initially the ovicidal efficacy of all extracts was tested at 50 mg/ml and at 1%, this last concentration for the methanolic extract of Elettaria cardamomum, by the Egg Hatch Assay. In those extracts with efficacy higher than 95%, the effective concentration required to inhibit 50% of egg hatching (EC) and their cytotoxicity, as the lethal dose 50 (LC), was also measured. The aqueous extracts of Aesculus hippocastanum, Isatis tinctoria, Chelidonium majus, E. cardamomum and Sisymbrium irio, with EC values ranging 1.30–2.88 mg/ml, and the aqueous extract of Jasminum polyanthum with a value of 6.41 mg/ml, showed the highest activities. The aqueous extract of J. polyanthum was the safest extract, followed by methanolic extract of E. cardamomum and aqueous extract of S. irio, all of them with a Selective Index higher than 1. According to our results, there is no correlation between the amount of total phenols or total tannins with the anthelmintic activity of the plants tested. Although results need to be interpreted with caution, as in vitro activity may not automatically translate into in vivo efficacy, those extracts with SI equal or higher than 1 and EC equal or lower than 6 mg/ml, could be taken into account for being used subsequently as feed or food additives in infected sheep., This study has been funded by the national project INIA (Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria: RTA2013-00064-C02-02), Ministry of Economy and Competitiveness (Ministerio de Economía y Competitividad: AGL 2016-79813-C2-1R),the European Regional Development Fund (Fondos Feder) and the Spanish“Ramón y Cajal”Programme, Ministry of Economy and Competitiveness (MMV, RYC-2015-18368).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics

  • Sepúlveda-Crespo, D.
  • Reguera, R.
  • Rojo Vázquez, Francisco Antonio
  • Balaña-Fouce, Rafael
  • Martínez Valladares, María
39 páginas, 3 figuras, 5 tablas., Helminthiasis is one of the gravest problems worldwide. There is a growing concern on less available anthelmintics and the emergence of resistance creating a major threat to human and livestock health resources. Novel and broad-spectrum anthelmintics are urgently needed. The free-living nematode Caenorhabditis elegans could address this issue through automated high-throughput technologies for the screening of large chemical libraries. This review discusses the strong advantages and limitations for using C elegans as a screening method for anthelmintic drug discovery. C elegans is the best model available for the validation of novel effective drugs in treating most, if not all, helminth infections, and for the elucidation the mode of action of anthelmintic candidates. This review also focuses on available technologies in the discovery of anthelmintics published over the last 15 years with particular attention to high-throughput technologies over conventional screens. On the other hand, this review highlights how combinatorial and nanomedicine strategies could prolong the use of anthelmintics and control resistance problems., Consejería de Educación, Junta de Castilla y León, Grant/Award Number: LE020P17; Ministerio de Economía y Competitividad, Grant/Award Numbers: AGL2016‐79813‐C2‐1R, RYC‐2015‐18368; European and Developing Countries Clinical Trials Partnership, Grant/Award Number: RIA2017NCT‐1845
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Screening marine natural products for new drug leads against trypanosomatids and malaria

  • Álvarez-Bardón, M.
  • Pérez-Pertejo, Yolanda
  • Ordóñez, C.
  • Sepúlveda-Crespo, D.
  • Carballeira, N.M.
  • Tekwani, B.L.
  • Murugesan, S.
  • Martínez Valladares, María
  • García-Estrada, Carlos
  • Reguera, R.M.
  • Balaña-Fouce, Rafael
42 páginas, 15 figuras, 1 tabla., Neglected Tropical Diseases (NTD) represent a serious threat to humans, especially for those living in poor or developing countries. Almost one-sixth of the world population is at risk of suffering from these diseases and many thousands die because of NTDs, to which we should add the sanitary, labor and social issues that hinder the economic development of these countries. Protozoan-borne diseases are responsible for more than one million deaths every year. Visceral leishmaniasis, Chagas disease or sleeping sickness are among the most lethal NTDs. Despite not being considered an NTD by the World Health Organization (WHO), malaria must be added to this sinister group. Malaria, caused by the apicomplexan parasite Plasmodium falciparum, is responsible for thousands of deaths each year. The treatment of this disease has been losing effectiveness year after year. Many of the medicines currently in use are obsolete due to their gradual loss of efficacy, their intrinsic toxicity and the emergence of drug resistance or a lack of adherence to treatment. Therefore, there is an urgent and global need for new drugs. Despite this, the scant interest shown by most of the stakeholders involved in the pharmaceutical industry makes our present therapeutic arsenal scarce, and until recently, the search for new drugs has not been seriously addressed. The sources of new drugs for these and other pathologies include natural products, synthetic molecules or repurposing drugs. The most frequent sources of natural products are microorganisms, e.g., bacteria, fungi, yeasts, algae and plants, which are able to synthesize many drugs that are currently in use (e.g. antimicrobials, antitumor, immunosuppressants, etc.). The marine environment is another well-established source of bioactive natural products, with recent applications against parasites, bacteria and other pathogens which affect humans and animals. Drug discovery techniques have rapidly advanced since the beginning of the millennium. The combination of novel techniques that include the genetic modification of pathogens, bioimaging and robotics has given rise to the standardization of High-Performance Screening platforms in the discovery of drugs. These advancements have accelerated the discovery of new chemical entities with antiparasitic effects. This review presents critical updates regarding the use of High-Throughput Screening (HTS) in the discovery of drugs for NTDs transmitted by protozoa, including malaria, and its application in the discovery of new drugs of marine origin., Financial support from the Ministerio de Economía y Competitividad (MINECO, AEI, FEDER, UE)[MINECO: AGL2016-79813-C2-1R and SAF2017-83575-R], the Junta de Castilla y León co-financed by FEDER, UE[LE020P17] to RBF and DBT, New Delhi [BT/IN/Spain/39/SM/2017-18] to MS are gratefully acknowledged. MAB(LE051-18) and DSC (LE020P17) are supported by a scholarship from the Junta de Castilla y León co-financed byFSE. MMV is supported by the Spanish “Ramon y Cajal” Programme Ministry of Economy and Competitiveness(Ministerio de Economia y Competitividad; MMV, RYC-2015-18368). We thank University of Leon for providingfunding to cover publication expenses.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis, bioevaluation and docking studies of some 2-phenyl-1H-benzimidazole derivatives as anthelminthic agents against the nematode Teladorsagia circumcincta

  • Escala, N.
  • Valderas García, Elora
  • Bardón, M.Á.
  • Castilla Gómez de Agüero, Verónica
  • Escarcena, R.
  • López-Pérez, J.L.
  • Rojo Vázquez, Francisco Antonio
  • San Feliciano, A.
  • Balaña-Fouce, Rafael
  • Martínez Valladares, María
  • Olmo, E.d.
12 páginas, 2 tablas, 4 figuras., Gastrointestinal nematode infections are the main diseases in herds of small ruminants. Resistance to the main established drugs has become a worldwide problem. The purpose of this study is to obtain and evaluate the in vitro ovicidal and larvicidal activity of some 2-phenylbenzimidazole derivatives on susceptible and resistant strains of Teladorsagia circumcincta. Compounds were prepared by known procedures from substituted o-phenylenediamines and arylaldehydes or intermediate sodium 1-hydroxyphenylmethanesulfonate derivatives. Egg Hatch Test (EHT), Larval Mortality Test (LMT) and Larval Migration Inhibition Test (LMIT) were used in the initial screening of compounds at 50 μM concentration, and EC values were determined for the most potent compounds. Cytotoxicity evaluation of compounds was conducted on human Caco-2 and HepG2 cell lines to calculate their Selectivity Indexes (SI). At 50 μM concentration, nine out of twenty-four compounds displayed more than 98% ovicidal activity on a susceptible strain, and four of them showed more than 86% on one resistant strain. The most potent ovicidal benzimidazole (BZ) 3 showed EC = 6.30 μM, for the susceptible strain, while BZ 2 showed the lowest EC value of 14.5 μM for the resistant strain. Docking studies of most potent compounds in a modelled Teladorsagia tubulin indicated an inverted orientation for BZ 1 in the colchicine binding site, probably due to its fair interaction with glutamic acid at codon 198, which could justify its inactivity against the resistant strain of T. circumcincta., We would like to express our gratitude to Dr. Dave Bartley at Moredun Research Institute for providing the triple-resistant strainof T. circumcincta. Authors thank Bioinformatic & Molecular Design Research Centre (BMDRC, Yonsey University, Seoul, Korea) and Idorsia Pharmaceuticals Ltd. (Allschwil, Switzerland) for compli-mentary access to preADMET and Osiris Data Warrior databases, respectively. RE thanks financiation from RICET-USAL ProgramRD16/0027/0018. Financial support came from MINECO: RETOS(AGL2016-79813-C2-1R/2R) and Junta de Castilla y León co-financed by FEDER, UE (LE020P17). EVG was funded by FPU16/03536, VCGA by Junta de Castilla y León and FSE (LE082-18), MAVby Junta de Castilla y León (LE051-18) and MMV by the Spanish “Ramon y Cajal” Programme (Ministerio de Economía y Competitividad; MMV, RYC-2015-18368), respectively.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Anthelmintic activity of aminoalcohol and diamine derivatives against the gastrointestinal nematode Teladorsagia circumcincta

  • Valderas García, Elora
  • De La Vega, J.
  • Álvarez Bardón, M.
  • Castilla Gómez de Agüero, Verónica
  • Escarcena, Ricardo
  • López-Pérez, J. L.
  • Rojo Vázquez, Francisco Antonio
  • San Feliciano, A.
  • del Olmo, Esther
  • Balaña-Fouce, Rafael
  • Martínez Valladares, María
11 páginas, 5 figuras, 4 tablas., Gastrointestinal nematodes (GIN) infections are a serious problem in livestock production due to the great economic losses they cause. Their control is increasingly difficult because of the rapid development of drug resistance and the limited number of available drugs. Therefore, this study evaluated 18 aminoalcohol and 16 diamine derivatives against eggs, first and third stage larvae from a susceptible and a resistant isolate of Tela-dorsagia circumcincta collected from sheep. The effectiveness of the in vitro anthelmintic activity of the com-pounds was evaluated using three different procedures: Egg Hatch Test (EHT), Larval Mortality Test (LMT) and Larval Migration Inhibition Test (LMIT). Those compounds with activities higher than 90 % in the initial screening at 50 μM were selected to determine their half maximal effective concentration (EC50). In parallel, cytotoxicity assays were conducted on Caco2 and HepG2 cell lines to calculate Selectivity Indexes (SI) for each compound. The diamine 30 presented the best results in preventing egg hatching, displaying the lowest EC50 value (1.01 ±0.04 μM) of all compounds tested and the highest SI (21.21 vs. Caco-2 cells). For the LMIT, the diamine 34 showed the highest efficacy, with EC50 values of 2.67 ±0.08 and 3.02 ±0.09 μM on the susceptible and resistant isolate of the parasite, respectively., We are grateful to Dave Bartley, from Moredun Research Institute for providing the triple-resistant isolate of T. circumcincta. RE thank the RICET contract (E07D401988BR) EC Programs. Financial support came from MINECO: RETOS (AGL2016-79813-C2-1R/2R) and Junta de Castilla y León (JCyL) co-financed by FEDER, UE (LE020P17). EVG was funded by FPU16/03536; JV, VCGA and MAB are recipients of Junta de Castilla y Leon and European Social Found (ESF)’s Fellowships Scheme for Doctoral Training Programs. (JCYL-USAL35B, LE082-18, LE051-18, respectively) and MMV by the Spanish “Ramon y Cajal” Programme (Ministerio de Economía y Competitividad; RYC-2015-18368)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Novel compound shows in vivo anthelmintic activity in gerbils and sheep infected by Haemonchus contortus

  • Valderas García, Elora
  • Escala, N.
  • Álvarez-Bardón, M.
  • Castilla Gómez de Agüero, Verónica
  • Cambra Pelletjá, María
  • González del Palacio, Laura
  • Vallejo, R.
  • De La Vega, J.
  • San Feliciano, A.
  • Del Olmo, E.
  • Martínez Valladares, María
8 páginas, 2 figuras, 2 tablas., The control of gastrointestinal nematodes in livestock is becoming increasingly difficult due to the limited number of available drugs and the rapid development of anthelmintic resistance. Therefore, it is imperative to develop new anthelmintics that are effective against nematodes. Under this context, we tested the potential toxicity of three compounds in mice and their potential anthelmintic efficacy in Mongolian gerbils infected with Haemonchus contortus. The compounds were selected from previous in vitro experiments: two diamine (AAD-1 and AAD-2) and one benzimidazole (2aBZ) derivatives. 2aBZ was also selected to test its efficacy in sheep. In Mongolian gerbils, the benzimidazole reduced the percentage of pre-adults present in the stomach of gerbils by 95% at a dose of 200 mg/kg. In sheep, there was a 99% reduction in the number of eggs shed in faeces after 7 days at a dose of 120 mg/kg and a 95% reduction in the number of worm adults present in the abomasum. In conclusion, 2aBZ could be considered a promising candidate for the treatment of helminth infections in small ruminants. © 2022, The Author(s)., Financial support came from MINECO: RETOS (AGL2016-79813-C2-1R/2R) and MICINN/AEI (PID2020- 119035RB-100). EVG was funded by FPU17/00627, FPU17/05346; VCGA, MAB, MCP and LGP are recipients of Junta de Castilla y León (JCyL) (LE082-18, LE051-18, LE135-19, LE096-20, respectively) and MMV by the Spanish “Ramon y Cajal” Programme (Ministerio de Economía y competitividad; MMV, RYC-2015-18368)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Benzimidazole and aminoalcohol derivatives show in vitro anthelmintic activity against Trichuris muris and Heligmosomoides polygyrus

  • Valderas García, Elora
  • Häberli, C.
  • Álvarez-Bardón, M.
  • Escala, N.
  • Castilla Gómez de Agüero, Verónica
  • Vega, J. De La
  • Olmo, E.
  • Balaña-Fouce, Rafael
  • Keiser, J.
  • Martínez Valladares, María
8 páginas, 4 tablas., Background: Infections by gastrointestinal nematodes cause significant economic losses and disease in both humans and animals worldwide. The discovery of novel anthelmintic drugs is crucial for maintaining control of these parasitic infections. Methods: For this purpose, the aim of the present study was to evaluate the potential anthelmintic activity of three series of compounds against the gastrointestinal nematodes Trichuris muris and Heligmosomoides polygyrus in vitro. The compounds tested were derivatives of benzimidazole, lipidic aminoalcohols and diamines. A primary screening was performed to select those compounds with an ability to inhibit T. muris L1 motility by > 90% at a single concentration of 100 µM; then, their respective IC50 values were calculated. Those compounds with IC50 < 10 µM were also tested against the adult stage of T. muris and H. polygyrus at a single concentration of 10 µM. Results: Of the 41 initial compounds screened, only compounds AO14, BZ6 and BZ12 had IC50 values < 10 µM on T. muris L1 assay, showing IC50 values of 3.30, 8.89 and 4.17 µM, respectively. However, only two of them displayed activity against the adult stage of the parasites: BZ12 killed 81% of adults of T. muris (IC50 of 8.1 µM) and 53% of H. polygyrus while BZ6 killed 100% of H. polygyrus adults (IC50 of 5.3 µM) but only 17% of T. muris. Conclusions: BZ6 and BZ12 could be considered as a starting point for the synthesis of further structurally related compounds. Graphical, Financial support came from MINECO: RETOS (AGL2016‑79813‑C2‑1R/2R) and Junta de Castilla y León co‑financed by FEDER, UE [LE020P17]. EVG was funded by FPU17/00627; VCGA and MAB are recipients of Junta de Castilla y Leon (JCyL) (LE082‑18, LE051‑18, respectively) and MMV by the Spanish “Ramon y Cajal” Programme (Ministerio de Economía y competitividad; MMV, RYC‑2015‑18368)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Further and new target-based benzimidazole anthelmintics active against Teladorsagia circumcincta

  • Escala, N.
  • Valderas García, Elora
  • Castilla Gómez de Agüero, Verónica
  • López-Pérez, J.L.
  • Rojo Vázquez, Francisco Antonio
  • Arturo San, F.
  • Martínez Valladares, María
  • Balaña-Fouce, Rafael
  • Del Olmo, E.
17 páginas, 5 figuras, 3 tablas., Helminth infections are one of the most prevalent parasitic diseases affecting animals and humans worldwide. Anthelmintic resistance to the main drugs used to control these infections in animals, especially ruminants, is a major global problem that needs urgent solutions. The purpose of this study was to design and obtain new benzimidazole (BZ) derivatives to evaluate their in vitro ovicidal and larvicidal activities. Based on previous results from 2-phenylbenzimidazoles and new docking studies of different BZ-containing scaffolds in Teladorsagia circumcincta tubulin four structural groups of BZs were selected. In addition to several new members of those previously reported 2-phenylBZs (type I), some twenty 2-aminoBZ derivatives (type II) and twenty-five BZ amides (types III and IV) were prepared and evaluated for their ability to inhibit egg hatching and larval motility of T. circumcincta with results superior to those previously achieved. Nine of the fifty-five BZs tested displayed ovicidal activity higher than 90%, and fourteen induced more than 30% larval death in the assays at 50 µM. The benzamide BZ 42 showed the best ovicidal EC50 value of 0.92 µM with a selectivity index > 100 respecting HepG2 cells, while the benzylamine BZ 13 attained a higher than 50% larvicidal activity. Notably, the amide BZ 39 displayed both ovicidal (100%) and larvicidal (>50%) activities. The SAR analysis and the docking studies carried out led to the conclusion that, in addition to the effects on tubulin, pending experimental confirmation, there must be other mechanisms by which the evaluated BZs prevent hatching and limit the mobility of the parasitic larvae., Financial support came from MINECO: RETOS (AGL2016-79813- C2-1R/2R) and Junta de Castilla y León co-financed by FEDER, UE [LE020P17]. EVG was funded by FPU17/00627; VCGA and MAB are recipients of Junta de Castilla y Leon (JCyL) (LE082-18, LE051- 18, respectively) and MMV by the Spanish “Ramon y Cajal” Pro- gramme (Ministerio de Economía y competitividad; MMV, RYC- 2015-18368)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies

  • Olmo, Esther del
  • Barboza, Bianca
  • Delgado-Esteban, María
  • Escala, Nerea
  • Jimenez-Blasco, Daniel
  • López-Pérez, José L.
  • Cillero de la Fuente, Laura
  • Quezada, Elías
  • Munín, Javier
  • Viña, Dolores
  • Bolaños, Juan P.
  • San Feliciano, Arturo
Monoaminooxidases (MAOs) are important targets for drugs used in the treatment of neurological and psychiatric disorders and particularly on Parkinson's Disease (PD). Compounds containing a trans-stilbenoid skeleton have demonstrated good selective and reversible MAO-B inhibition. Here, twenty-two (Z)-3-benzylidenephthalides (benzalphthalides, BPHs) displaying a trans-stilbenoid skeleton have been synthesised and evaluated as inhibitors of the MAO-A and MAO-B isoforms. Some BPHs have selectively inhibited MAO-B, with IC50 values ranging from sub-nM to μM. The most potent compound with IC50 = 0.6 nM was the 3',4'-dichloro-BPH 16, which showed highly selective and reversible MAO-B inhibitory activity. Furthermore, the most selective BPHs displayed a significant protection against the apoptosis, and mitochondrial toxic effects induced by 6-hydroxydopamine (6OHDA) on SH-SY5Y cells, used as a cellular model of PD. The results of virtual binding studies on the most potent compounds docked in MAO-B and MAO-A were in agreement with the potencies and selectivity indexes found experimentally. Additionally, related to toxicity risks, drug-likeness and ADME properties, the predictions found for the most relevant BPHs in this research were within those ranges established for drug candidates., This work was supported by grants from the Spanish government MINECO-Challenges projects AGL2016-79813-C2-1-R and AGL2016-79813-C2-2-R. Dolores Viña thanks the financial support from the Consellería de Cultura, Educación e Ordenación Universitaria (EM2014/016 and Centro singular de investigación de Galicia acreditación 2016‐2019, ED431G/05) and the European Regional Development Fund (ERDF). Juan P. Bolaños is funded by the European Regional Development Fund, Agencia Estatal de Investigación (PID2022-138813OB-I00), HORIZON-MSCA-2021-DN-01 (ETERNITY, 101072759 ), Fundación La Caixa ( HR23-00793 ), Instituto de Salud Carlos III ( CB16/10/00282 ), Junta de Castilla y León ( CS/151P20 and Escalera de Excelencia CLU-2017-03 ). José Luis López-Pérez thanks SENACYT of Panama for a SNI stimulus award., Peer reviewed